Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insight Molecular Diagnostics (IMDX) Acquisitions (2020 - 2021)

Insight Molecular Diagnostics' Acquisitions history spans 2 years, with the latest figure at $607000.0 for Q1 2021.

  • For Q1 2021, Acquisitions fell 90.19% year-over-year to $607000.0; the TTM value through Dec 2021 reached $607000.0, down 90.19%, while the annual FY2021 figure was $607000.0, 90.19% down from the prior year.
  • Acquisitions for Q1 2021 was $607000.0 at Insight Molecular Diagnostics, down from $6.2 million in the prior quarter.
  • Across five years, Acquisitions topped out at $6.2 million in Q1 2020 and bottomed at $607000.0 in Q1 2021.